title: Systemic agmatine attenuates tactile allodynia in two experimental neuropathic pain models in rats.
abstract: Recent evidence suggests that agmatine, an endogenous polyamine metabolite, might be an important neurotransmitter in central nervous system and has potential as a treatment of pain. The aim of our study was to evaluate the effect of agmatine on allodynia in two experimental neuropathic pain models, the spinal nerve ligation (SNL) model and the streptozocin (STZ)-induced diabetic neuropathy in rats, and to determine if the N-methyl-D-aspartate (NMDA) receptor antagonists and the nitric oxide synthase (NOS) inhibitors influence this effect of agmatine. Nerve injury was produced by tight ligation of the left L5 and L6 spinal nerves, and diabetic neuropathy is induced with the injection of a single dose of STZ; these procedures resulted in tactile allodynia in the hindpaw. Tactile allodynia was detected by application of von Frey filaments to the plantar surface of the foot. Agmatine reduced mechanical allodynia with its higher doses. Dizocilpine maleate (MK-801), a NMDA receptor antagonist, and the NOS inhibitors, N(G)-nitro-L-arginine methyl ester and 7-nitroindazole, did not influence the antiallodynic effect of agmatine. These results suggest that agmatine has an antiallodynic effect in both spinal nerve ligation and diabetic models and may be a promising drug in the treatment of neuropathic pain.
authors.affiliation: Department of Pharmacology, Faculty of Medicine, Trakya University, 22030-, Edirne, Turkey. hkaradag@trakya.edu.tr
authors.forename: Hakan C
authors.initials: HC
authors.lastname: Karadag
authors.forename: Ahmet
authors.initials: A
authors.lastname: Ulugol
authors.forename: Melek
authors.initials: M
authors.lastname: Tamer
authors.forename: Yesim
authors.initials: Y
authors.lastname: Ipci
authors.forename: Ismet
authors.initials: I
authors.lastname: Dokmeci
mesh_terms: D000547:Amantadine / Q000627:therapeutic use*; D018712:Analgesics, Non-Narcotic / Q000627:therapeutic use*; D000818:Animals; D003929:Diabetic Neuropathies / Q000139:chemically induced / Q000150:complications; D005260:Female; D008026:Ligation; D008297:Male; D010146:Pain / Q000188:drug therapy* / Q000209:etiology / Q000523:psychology; D017288:Pain Threshold; D010523:Peripheral Nervous System Diseases / Q000150:complications*; D051381:Rats; D017208:Rats, Wistar; D013127:Spinal Nerves; D014110:Touch
chemical_list: D018712:Analgesics, Non-Narcotic; D000547:Amantadine